LifeMD sees Q1 revenue $48M-$49M, consensus $45.61M

Sees Q1 adjusted EBITDA loss $4M-$5M. The company said, “Adjusted EBITDA expected to return to profitability in Q2 as customer acquisition costs decline sequentially and the substantial rise in patient volumes becomes accretive for the balance of 2026.”